Initial INDs placed on hold, product novelty
| Investigational new drugs | All initial INDs on hold, n=125 | Initial INDs for rare diseases on hold, n=25 | Initial INDs for non-rare diseases on hold, n=100 |
|---|---|---|---|
| Novel, n (%) | 77 (61.6) | 14 (56.0) | 63 (63.0) |
| Repurposed, n (%) | 48 (38.4) | 11 (44.0) | 37 (37.0) |
IND, Investigational New Drug application.